Serum Levels of Soluble Form of Fas Molecule in Patients with Congestive Heart Failure
- 1 June 1997
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 79 (12) , 1698-1701
- https://doi.org/10.1016/s0002-9149(97)00228-2
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare (5S-3)
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 23 references indexed in Scilit:
- Two tumour necrosis factor receptors: structure and functionPublished by Elsevier ,2000
- Elevated levels of soluble Fas in systemic lupus erythematosus: Comment on the article by Knipping et alArthritis & Rheumatism, 1996
- Stretch-induced programmed myocyte cell death.Journal of Clinical Investigation, 1995
- Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions.The Journal of Experimental Medicine, 1994
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.Journal of Clinical Investigation, 1993
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991
- A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.The Journal of Experimental Medicine, 1989